Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Radiofrequency exposure can stimulate hair growth by increasing IGF-1 in hair follicle cells.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

miR-140-5p in certain cell vesicles helps hair growth by boosting cell proliferation.

COVID-19 may harm male fertility and damage the reproductive system.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

EH-MSCs may help treat hair loss by boosting regeneration and reducing inflammation.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.